FINEORG - Fine Organic Industries Limited Share Price

Management's outlook for Fine Organic Industries Limited reflects confidence amidst a challenging macroeconomic environment. The company navigated increased raw material costs and logistics challenges effectively, reporting a revenue increase of 6.9% to INR 2,269 crores for FY '25, up from INR 2,123 crores the previous year. However, EBITDA declined by 4% to INR 512.9 crores, with EBITDA margins at 22.6%. The profit after tax (PAT) was slightly lower at INR 410.5 crores compared to INR 411.9 crores in FY '24.

Key forward-looking points include:

1. Expansion Plans: The company has prioritized expansions, including a new SEZ manufacturing facility at JNPT in Maharashtra, with a total estimated investment of INR 750 crores, expected to be completed within 18 to 24 months.
2. U.S. Operations: A new manufacturing facility is in the pipeline in the U.S. to enhance local presence, reduce logistics costs, and improve compliance with local regulations. The specific land acquisition is anticipated to be announced soon.
3. Funding Strategy: With a cash balance of around INR 1,000 crores, management indicated that funds would be allocated towards both SEZ and U.S. expansions while preserving some cash for future mergers and acquisitions (M&A) opportunities.
4. Market Dynamics: Strong domestic demand persists, with an increased focus on freeing up existing capacities from exports to meet growth in India.
5. Project Timeline: Management reported a cautious but optimistic approach to U.S. operations, indicating a phased strategy to mitigate risks associated with labor laws and regulatory compliance, which include initial conservative capacity setups.

Overall, Fine Organic's strategy positions it for growth by leveraging both domestic and international markets while adapting to evolving consumer needs and operational efficiencies.

1. Question: Can you now give us the sense on what is the capex in the JNPA, the new facility that we are planning? Answer: Our total capex for the new facility at JNPA is anticipated to be around INR 750 crores, though this will be implemented in stages as we progress through the approvals needed for construction.

2. Question: Will we be able to consume all of our cash in the expansion plan in the U.S. as well, or will there still be cash left? Answer: Yes, we are looking at both the SEZ and U.S. expansions, which will consume a significant portion of our cash reserves, currently around INR 1,000 crores. However, we will retain some cash for potential M&A opportunities we are exploring.

3. Question: How do you see growth over the next 3 to 5 years post-expansion? Answer: While I can't provide specific numbers, I'm confident that both U.S. and SEZ expansions will significantly boost our capacities. The first phases will easily fill existing export demands. This gives us room for domestic growth as well.

4. Question: What is your readiness to tackle U.S. regulations and labor laws? Answer: We are cautious about U.S. operations as this is our first plant there. We need to understand local regulations and hire the right management. We're prepared to learn from the challenges we might face during this initial phase of operations.

5. Question: Can you elaborate on the investment in other financial assets? Answer: We have invested approximately INR 200 crores in long-term fixed deposits, which is reflected as an increase in our non-current assets. This strategy helps ensure liquidity while also earning returns.

6. Question: What's the status of the Thailand expansion related to super specialty products? Answer: We've received the necessary FDA approvals and started trial production of these specialty products. Our production team in Thailand is confident, and we are running trials smoothly, with commercial lots also being produced.

7. Question: Will the U.S. expansion focus solely on manufacturing the same products as in India? Answer: Initially, the U.S. facility will produce products we currently export from India. As we progress, we intend to expand our range to include both existing and new products.

8. Question: Are you open to raising funds or debt for the upcoming expansions? Answer: Yes, we are open to raising funds through debt financing. Our expansion strategies will be financed through a combination of internal accruals and debt.

9. Question: What do you expect your capacity to be in the U.S. compared to India? Answer: While I can't provide exact figures just yet, we expect the capacity in the U.S. to be higher than in India. We are still working out the specifics as negotiations with suppliers are underway.

10. Question: How would you respond to increasing domestic demand while managing underutilized capacity? Answer: Our Patalganga plant is focused on food additives and is ramping up quickly. We foresee full utilization by early FY '26 but cannot manufacture anything outside of food additives there. Hence, JNPA will help meet rising domestic demand by freeing capacity from existing plants.